Inhibition Of acetyl-CoA Carboxylase Research Articles

Management of Herbicide resistant Phalaris minor: A Review

Littleseed canarygrass (Phalaris minor Retz), an annual species of the family Poaceae, is a major weed problem in many wheat-producing countries. The excessive dependence on herbicides for its control led to the evolution of multiple herbicides resistance and yield losses. The first case of resistant P. minor in India was to the Photosystem-II inhibitor isoproturon in the early 1990’s. P. minor has been found resistant to Acetolactate Synthase (ALS) inhibitors, Acetyl-CoA Carboxylase (ACCase) inhibitors, Photosystem II inhibitors. It is highly competitive and in severe cases can cause complete crop failure, forcing farmers to harvest their crop as fodder or ploughing the standing crop along with weeds. For management of these multiple herbicide resistant P. minor, pyroxasulfone, pendimethalin, flumioxazin, trifluralin and flufenacet can be used as alternative herbicides. Moreover, in-depth biological and ecological studies on P. minor should be carried out for devising integrated weed management strategies. The long-term strategies of efficient weed management and sustainability of wheat production should include the use of alternative herbicides, herbicide mixture, crop rotation along with other non-chemical methods like manual removal of weeds, mulching, Summer ploughing etc providing the competitive advantages to the wheat crop over P. minor, at the same time increasing the profitability of the farmer by controlling the weed effectively and reducing the selection pressure on the weeds which will inturn reduce the resistance development in weeds

Repurposing a human acetyl-CoA carboxylase inhibitor firsocostat to treat fungal candidiasis alone and in combination.

Opportunistic fungal infections, particularly caused by Candida albicans, remain a common cause of high morbidity and mortality in immunocompromised patients. The escalating prevalence of antifungal drug resistance necessitates the immediate exploration of alternative treatment strategies to combat these life-threatening fungal diseases. In this study, we investigated the antifungal efficacy of firsocostat, a human acetyl-CoA carboxylase (ACC) inhibitor, against C. albicans. Firsocostat alone displayed moderate antifungal activity, while combining it with voriconazole, itraconazole, or amphotericin B exhibited synergistic effects across almost all drug-sensitive and drug-resistant C. albicans strains tested. These observed synergies were further validated in two mouse models of oropharyngeal and systemic candidiasis, where the combination therapies demonstrated superior fungicidal effects compared to monotherapy. Moreover, firsocostat was shown to directly bind to C. albicans ACC and inhibit its enzymatic activity. Sequencing spontaneous firsocostat-resistant mutants revealed mutations mapping to C. albicans ACC, confirming that firsocostat has retained its target in C. albicans. Overall, our findings suggest that repurposing firsocostat, either alone or in combination with other antifungal agents, holds promising potential in the development of antifungal drugs and the treatment of candidiasis.

Retraction: Hypothalamic Inhibition of Acetyl-CoA Carboxylase Stimulates Hepatic Counter-Regulatory Response Independent of AMPK Activation in Rats.

Retraction: Hypothalamic Inhibition of Acetyl-CoA Carboxylase Stimulates Hepatic Counter-Regulatory Response Independent of AMPK Activation in Rats.

Convergent Syntheses of Isomeric Imidazolospiroketones as Templates for Acetyl-CoA Carboxylase (ACC) Inhibitors.

The synthesis of imidazole fused spirocyclic ketones as templates for acetyl-CoA carboxylase (ACC) inhibitors is reported. By completing the spirocyclic ring closure via divergent pathways, the synthesis of these regioisomers from common intermediates was developed. Through an aldehyde homologation/transmetalation strategy, one isomer was formed selectively. The second desired isomer was obtained via an intramolecular aromatic homolytic substitution reaction. Preparation of these isomeric spiroketones provided templates which, upon elaboration, led to key structure-activity relationship (SAR) points for delivery of potent ACC inhibitors.

Effect of Green and Red Thai Kratom (Mitragyna speciosa) on pancreatic digestive enzymes (alpha-glucosidase and lipase) and acetyl-carboxylase 1 activity: A possible therapeutic target for obesity prevention.

Regular use of Thai kratom has been linked to reduced blood triglyceride levels and body mass index (BMI) in healthy individuals. We analyzed Green Thai Kratom (GTK) and Red Thai Kratom (RTK) to investigate their effects on pancreatic digestive enzymes. The ethanol extracts of GTK and RTK inhibited lipase activity more strongly than alpha-glucosidase activity, suggesting the presence of lipase inhibitors. Mitragynine, the major compound in GTK, showed potent lipase inhibition and moderate alpha-glucosidase inhibition. Quercetin, found in both extracts, strongly inhibited alpha-glucosidase but had limited effects on lipase. These findings suggest that mitragynine and quercetin may hinder triglyceride and starch digestion. Combination inhibition studies revealed synergistic effects between mitragynine and quercetin on alpha-glucosidase activity. Additionally, both GTK and RTK extracts reduced fat accumulation in 3T3-L1 adipocyte cells, with quercetin specifically inhibiting Acetyl-CoA carboxylase 1 (ACC1), a key enzyme in fatty acid biosynthesis. Thus, GTK and RTK extracts, particularly mitragynine and quercetin, exhibit potential anti-obesity effects. We report the novel finding that Thai kratom inhibits de novo fatty acid synthesis by targeting ACC1, resulting in decreased fat accumulation in adipocytes. Regular use of Thai kratom in specific populations may improve blood triglyceride levels and reduce BMI by inhibiting lipase, alpha-glucosidase, and ACC1 activity. Further clinical trials are needed to determine optimal dosage, duration, toxicity levels, and potential side effects of Kratom use.

Fine-tuning gene expression of regulator AdmX for improved biosynthesis of andrimid in Erwinia persicina BST187.

Andrimid is a potent antibiotic that inhibits acetyl-CoA carboxylase. However, its low biological yield and complex chemical synthesis have hindered its large-scale application. In this study, we found that the LysR-type transcriptional activator AdmX controls andrimid yield by adjusting its expression level in the andrimid-producing bacterium Erwinia persicina strain BST187. Our results showed that gradually increasing of admX transcriptional levels significantly improved andrimid yield, while the yield declined when admX was overexpressed excessively. To further estimate the effect of AdmX on andrimid promotion, we fitted and developed a model which was y = -0.5576x2 + 61.945x + 800.63 (R2 = 0.9591), where x represents the admX transcriptional level and y represents andrimid yield. Andrimid yield of admX overexpression strain BST187ΔadmX/pET28a-Pgap-1::admX was greatly improved by 260%, which was reported for the first time that andrimid yield could be promoted by genetic engineering. Thus, this study provides important insights that the biosynthesis of andrimid would be improved by bioengineering and sheds lights on the potential application of andrimid in both biomedicine and bioagricultural manipulation with its large-scale production in the future. KEY POINTS: • Andrimid production can be greatly promoted by genetic engineering on non-model chassis. • The relationship between AdmX abundance and andrimid yield in Erwinia persicina strain BST187 might be parabolic. • Erwinia persicina BST187 combined with chassis modification enable the promising applications in andrimid industrialization.

Analysis of multi-disease targeting effect of phytochemicals by AMPK stimulation– diabetes: A computational approach

Diabetes is a silent killer and a metabolic syndrome characterized by hyperglycemia that has been exponentially increasing in recent years. There is a need to develop therapeutic agents to control hyperglycemia and its secondary complications as well as protect and revive beta cells in diabetic patients. The target for first-line diabetes treatment is the adenosine monophosphate protein kinase (AMPK), which participates in cellular energy metabolism through phosphorylation of metabolic enzymes and transcription regulators. This study examined the drug-related properties as well as lead preparation of Catharanthus roseus alkaloids and testing molecular interaction at the AMPK targets to confirm their anti-diabetic effect. A control drug metformin and a library of 85 molecules of C. roseus alkaloids were crossed with the ADMET test, followed by the investigation of molecular interaction tested on AMPK1 and AMPK2 targets through an in silico docking process. Vindolinine (CID: 24148538), vindoline (CID: 425978), (+)-vindorosine (CID: 261578), Cr-1 (CID: 5315746), and Cr-2 (CID: 59908094) had passed the ADMET test. Molecular interaction of the tested C. roseus alkaloids on AMPK1 and AMPK2 targets had potential energy that varied from −7.4 to −5.3 kcal/mol, whereas binding energies of −4.0 kcal/mol for AMPK1-metformin interaction and −4.2 kcal/mol for AMPK2-metformin interaction were observed. The tested C. roseus alkaloids were shown to be more potent activators of AMPK than the control drug. All five biomolecules of C. roseus acted as modulators that have the potential to stimulate AMPK, reduce glucose production, and increase glucose utilization in hepatocytes. In addition, they diminished insulin resistance and secondary complications of diabetes by inhibiting acetyl-CoA carboxylase, regulating cholesterol levels and macrophage, and reviving beta cells in Type 2 diabetes. These results provided the foundation for developing new multi-disease-targeting drugs that can treat diabetes, obesity, cardiovascular disease, cancer, and other diseases by the stimulation of AMPK1 and AMPK2 targets.

Cytochrome P450s-Involved Enhanced Metabolism Contributes to the High Level of Nicosulfuron Resistance in Digitaria sanguinalis from China.

Large crabgrass (Digitaria sanguinalis (L.) Scop.) is one of the major malignant grass weeds in Chinese maize (Zea mays L.) fields, and it has recently developed resistance to the acetolactate synthase (ALS)-inhibiting herbicide nicosulfuron. This study focused on a suspected nicosulfuron-resistant (R) population (LJ-01) of D. sanguinalis, collected from Lujiang County in Anhui Province, China, to explore the resistance level and potential resistance mechanism. Whole-plant dose-response testing confirmed that the LJ-01 population evolved a high level of resistance to nicosulfuron (11.5-fold) compared to the susceptible (S) population, DY-02. The ALS gene sequencing and relative expression assay of the R plants indicated that target gene mutation and overexpression were not responsible for the resistance phenotype. However, pretreatment with malathion, a known cytochrome P450 monooxygenase (P450) inhibitor, alleviated the resistance of the R population to nicosulfuron by approximately 36%. High-performance liquid chromatography (HPLC) analysis revealed that the R plants metabolized nicosulfuron faster than the S plants. Moreover, cross-resistance testing suggested that the R population exhibited low levels of resistance to thifensulfuron-methyl and pyrazosulfuron-ethyl, but it remained susceptible to rimsulfuron. Multiple resistance patterns showed that the R population evolved low resistance to the photosystem inhibitors bromoxynil octanoate and atrazine and sensitivity to the acetyl-CoA carboxylase (ACCase) inhibitor cyhalofop-butyl and the 4-hydroxyphenylpyruvate dioxygenase (HPPD) inhibitors tembotrione, mesotrione, and topramezone. This study reports, for the first time, the simultaneous resistance to ALS and different photosystem inhibitors in D. sanguinalis. The nicosulfuron resistance observed in the R population could primarily be attributed to an enhanced metabolism involving P450 enzymes.

Emerging possibilities in the advancement of herbicides to combat acetyl-CoA carboxylase inhibitor resistance

Acetyl-CoA carboxylase (ACCase: EC 6.4.1.2) is one of the essential biotins containing enzymes required by plants for fatty acid synthesis and elongation. The unique enzyme is present in its homomeric form in all the Gramineae family, making it a suitable target for developing herbicides selectively against weeds of the Gramineae family. One such example is infestation of Phalaris minor in winter wheat crop fields, where aryloxyphenoxypropionates (FOP); cyclohexanediones (DIM) and phenyl pyrazoline (DEN) group of ACCase inhibiting herbicides are used. However, the increasing number of ACCase herbicide resistant weed populations has compelled agro-scientists to seek varied possibilities for weed control, through Integrated Weed Management (IWM) strategies. Developing new potential herbicides to regain sensitivity in weeds could be an approach to weed control. The current advancement in computational techniques could be of aid in developing new herbicide-like molecules by exploring the genomics, proteomics and structural details of catalytic sites of herbicide action in crops as well as weeds.

ACCase gene mutations and P450-mediated metabolism contribute to cyhalofop-butyl resistance in Eleusine indica biotypes from direct-seeding paddy fields

Eleusine indica causes problems in direct-seeding rice fields across Jiangsu Province in China. Long-term application of chemical herbicides has led to the widespread evolution of resistance in E. indica. In this study, we surveyed the resistance level of cyhalofop-butyl (CyB) in 19 field-collected E. indica biotypes, and characterized its underlying resistance mechanisms. All 19 biotypes evolved moderate- to high-level resistance to CyB (from 5.8- to 171.1-fold). 18 biotypes had a target-site mechanism with Trp-1999-Ser, Trp-2027-Cys, or Asp-2078-Gly mutations, respectively. One biotype (JSSQ-1) was identified to have metabolic resistance, in which malathion pretreatment significantly reduced the CyB resistance, and cyhalofop acid was degraded 1.7- to 2.5-times faster in this biotype compared with a susceptible control. Furthermore, the JSSQ-1 biotype showed multiple resistance to acetyl-CoA carboxylase (ACCase) inhibitor metamifop (RI = 4.6) and fenoxaprop-p-ethyl (RI = 5.1), acetolactate synthase (ALS) inhibitor imazethapyr (RI = 4.1), and hydroxyphenylpyruvate dioxygenase (HPPD) inhibitor mesotrione (RI = 3.5). In addition, 11 out of 19 E. indica biotypes exhibited multiple resistance to glyphosate. This research has identified the widespread occurrence of CyB resistance in E. indica, attributed to target-site mutations or enhanced metabolism. Moreover, certain biotypes have exhibited resistance to multiple herbicides or even cross-resistance. Consequently, there is an urgent need to implement diverse weed management practices to effectively combat the proliferation of this weed in rice fields.

849-P: Antidiabetic Effects of TLC-3595, a Selective ACC2 Inhibitor, in ZDF Rats

Background: TLC-3595 is a potent (IC50=14nM), selective, small molecule, allosteric inhibitor of acetyl-CoA carboxylase 2 (ACC2). TLC-3595 provides a novel therapeutic approach for type 2 diabetes (T2D), via reduction in intramyocellular lipid (IMCL) content, that is complementary to approved therapies. Reduced IMCL strongly correlates with insulin sensitivity (IS). Here, we demonstrate antidiabetic effects of TLC-3595 in Zucker Diabetic Fatty (ZDF) rats. Methods: IMCL was measured by 1H-MRS. T2D progression and IS by hyperinsulinemic-euglycemic clamp were assessed in 30% diet-restricted ZDF rats treated with TLC-3595 (1.67, 5, or 15mg/kg) or pioglitazone (Pio, 0.75mg/kg) daily for 5-12 weeks. Results: TLC-3595 or an analog caused rapid and sustained IMCL reduction (~50%) in lean and dysmetabolic rodents. TLC-3595 enhanced systemic fatty acid oxidation (increased plasma beta-hydroxybutyrate) and reduced cardiac lipid in ZDF rats. TLC-3595 dose-dependently delayed β-cell failure in ZDF rats and was non-inferior to Pio for reductions in hyperglycemia (15-25% lower glucose AUC) and HbA1c (0.6-1.6% vs. vehicle) (Fig A, B). TLC-3595 improved IS and increased clamp glucose infusion rate by 29%, (Fig C). Conclusion: TLC-3595 reduced IMCL, improved IS, and delayed T2D progression comparable to Pio in ZDF rats. These data provide strong rationale for evaluation of TLC-3595 to treat insulin resistance and T2D. Disclosure A. Vijayakumar: Employee; OrsoBio Inc, Gilead Sciences, Inc. E. Murakami: Employee; OrsoBio. R.S. Huss: Employee; OrsoBio, Inc. Stock/Shareholder; OrsoBio, Inc. N. Sroda: None. A. Shimazaki: Employee; Shionogi & Co. Ltd. Y. Kashiwagi: Employee; Shionogi & Co. Ltd. R.P. Myers: Employee; OrsoBio, Inc. Stock/Shareholder; OrsoBio, Inc. M. Subramanian: Other Relationship; OrsoBio Inc. G.I. Shulman: Other Relationship; AstraZeneca, Merck & Co., Inc., Janssen Research & Development, LLC. Consultant; Novo Nordisk. Other Relationship; iMetabolic Biopharma Corporation, Maze Therapeutics, 89bio, Inc. Consultant; DiCerna Pharmaceuticals, Inc. Other Relationship; Equator Therapeutics, Inc., Generian Pharmaceuticals. Stock/Shareholder; Levels Health, Inc. Other Relationship; Fortress Biotech, Inc. Consultant; Bayer Consumer Care AG, Kriya Therapeutics, Arrowhead Pharmaceuticals, Inc., ESPERION Therapeutics, Inc. Other Relationship; OrsoBio, Aro Biotherapeutics Company.

Acetyl-CoA carboxylase 1 deletion reduces platelet phospholipid and alters thrombus formation

Acetyl-CoA carboxylase (ACC) is the key enzyme regulating de novo lipogenesis (DNL). In recent years, ACC inhibitors has been of great interest to handle a wide range of diseases, especially cancers and cardiovascular diseases. However, the impact of its inhibition on hemostasis and thrombosis remains under-investigated. We previously demonstrated that ACC1 activation promotes thrombus formation by increasing platelet phospholipid content and thromboxane A2 generation. Here, we sought to evaluate whether ACC1 platelet-specific deletion may affect platelet functions and by decreasing phospholipid content. To test this hypothesis we generated a new Cre transgenic mouse strain in which ACC1 is specifically deleted in megakaryocyte and platelet (GpIbCre±x ACC1 flx/flx mouse). Lipidomics analysis was carried out on the commercial Lipidyzer platform. Thromboxane A2 secretion was evaluated by ELISA. Platelet functions were assessed in vitro by aggregometry and ex vivo by flow chamber assay. Thrombus growth was analyzed in vivo with intravital microscopy. As expected, ACC1 deletion was restricted to megakaryocytic lineage. Hematological parameters show a platelet count decrease (30%) and a platelet volume increase (31%) in ACC1 knockout mice (ACC1 pKO) compared to the control mice. In agreement with our hypothesis, lipidomics analyses highlight a significant reduction in arachidonic acid containing phosphotidylethanolamine plasmalogen in ACC1 KO platelets. Logically, thromboxane A2 generation (upon thrombin or CRP stimulation) is also altered in ACC1 pKO mice in comparison to controls. This decrease in phospholipid content is associated with a default in thrombin and CRP-induced platelet aggregation and with impaired dense granules secretion. In line with these results, platelet-specific ACC1 deletion reduces thrombus growth and fibrinogen receptor activation. Platelet-specific ACC1 deletion leads to a decrease in phospholipid content which, in turn, decreases platelet thromboxane A2 generation, dense granules secretion and platelet aggregation. Thrombus formation is also reduced in platelet-specific ACC1 knockout mice, highlighting the importance of de novo lipogenesis and ACC-produced lipids in the regulation of platelet functions.

Fetal hyperglycemia and the origin of adult obesity

Fetal Hyperglycemia (FH) plays a critical role in adult obesity. FH occurs upon fetal exposure to high maternal glucose during Gestational Diabetes, resulting in hyperinsulinemia and increased fetal fat deposition. At birth, these infants are larger than normal babies, hypoglycemic and hyperinsulinemic and have a higher risk of adult-onset metabolic disorders such as obesity, Type 2 Diabetes and non-alcoholic fatty liver disease (NAFLD). Although in utero glucose exposure provides evidence in the above-mentioned conditions the molecular mechanisms remain unclear. Using a Zebrafish model of FH, we aim to test the hypothesis that FH increases hepatic de novo lipogenesis causing obesity later in life. Methods: We developed a novel Zebrafish model of FH by exposing embryos to high glucose (4.5% w/v) at day 4 post fertilization (4 dpf) during the last day of embryogenesis. At 5 dpf the glucose media was replaced by regular media with or without the Acetyl-CoA Carboxylase (acca) inhibitor ND646 for additional 24 hrs followed by embryo collection. Adult fish were raised from glucose-exposed embryos on a normal diet. Fat mass was assessed by Echo-MRI and glucose levels by glucometer. The substrate of de novo lipogenesis, malonyl CoA level was quantified by ELISA and triglycerides by colorimetry. Insulin expression (visualized by whole mount in-situ hybridization), lipogenic (acca), beta oxidation [(Carnitine palmitoyltransferase, (cpt1/2)] and gluconeogenic [(Glucagon (gcga), Glucose-6-Phosphatase (G6Pase), Phosphoenolpyruvate carboxykinase (pck1)] markers were quantified by RT-qPCR. Oil-Red-O staining (ORO) was used to detect lipid accumulation and quantified using spectrophotometry, while Nile red staining was used to detect adipocyte accumulation. Results: Zebrafish embryos become transiently hyperglycemic and hyperinsulinemic after 24 hrs of glucose exposure at 5 dpf. Surprisingly, despite being normoglycemic glucose-exposed embryos at 6 dpf showed significantly higher levels of hepatic lipid accumulation (48%) and de novo lipogenesis (acca and malonyl CoA) as well as markers of gluconeogenesis (gcga, G6Pase, pck1) and beta oxidation (cpt1/2), compared to controls. Interestingly, adult fish (3 months) become obese (fat mass, 2.5±0.2 vs 3.7±0.2) and develop epicardial fat deposition, despite being normoglycemic. At the molecular level, adult fish have increased fasting hepatic de novo lipogenesis, as indicated by elevated acca expression and malonyl CoA levels which was associated with higher hepatic triglyceride levels (1.5-fold) compared to adult fish raised from unexposed embryos. ND 646 administration reduced lipid accumulation in embryos. The effect of ND 646 on adult fish is under evaluation. Conclusion: Together our results show that FH induces persistent increase in whole embryonic and adult hepatic de novo lipogenesis and its pharmacological inhibition could be promising therapeutic intervention to rescue FH-induced adulthood obesity. National Institute of Health grant (P20 GM104357) This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

A Reinvestigation of the Role of the Sorbic Acid Tail on the Antibacterial and Anti-Tuberculosis Properties of Moiramide B.

Due to worldwide increasing resistances, there is a considerable need for antibacterial compounds with modes of action not yet realized in commercial antibiotics. One such promising structure is the acetyl-CoA carboxylase (ACC) inhibi-tor moiramide B which shows strong antibacterial activity against gram-positive bacteria such asBacillus subtilisand weaker activities against gram-negative bacteria. However, the narrow structure-activity relationship of the pseudopeptide unit of moiramide B represents a formidable challenge for any opti-mization strategy.​In contrast, the lipophilic fatty acid tail is considered an unspe-cific vehicle responsible only for the transport of moiramide into the bac-terial cell. Here we show that the sorbic acid unit, in fact, is highly relevant for ACC inhibition. A hitherto undescribed sub-pocket at the end of the sorbic acid channel binds strongly aromatic rings andallows the development of moiramide derivatives with altered antibacterial profiles including anti-tubercular activity.

The role of ChREBP in carbohydrate sensing and NAFLD development.

Excessive sugar consumption and defective glucose sensing by hepatocytes contribute to the development of metabolic diseases including type 2 diabetes mellitus (T2DM) and nonalcoholic fatty liver disease (NAFLD). Hepatic metabolism of carbohydrates into lipids is largely dependent on the carbohydrate-responsive element binding protein (ChREBP), a transcription factor that senses intracellular carbohydrates and activates many different target genes, through the activation of de novo lipogenesis (DNL). This process is crucial for the storage of energy as triglycerides in hepatocytes. Furthermore, ChREBP and its downstream targets represent promising targets for the development of therapies for the treatment of NAFLD and T2DM. Although lipogenic inhibitors (for example, inhibitors of fatty acid synthase, acetyl-CoA carboxylase or ATP citrate lyase) are currently under investigation, targeting lipogenesis remains a topic of discussion for NAFLD treatment. In this Review, we discuss mechanisms that regulate ChREBP activity in a tissue-specific manner and their respective roles in controlling DNL and beyond. We also provide in-depth discussion of the roles of ChREBP in the onset and progression of NAFLD and consider emerging targets for NAFLD therapeutics.

Confirmation and chemical control of acetyl-CoA carboxylase- and acetolactate synthase-resistant Japanese foxtail in China

Japanese foxtail (Alopecurus japonicus Steud.) has developed resistance to multiple post-emergence herbicides in China. Hence, identification of alternative strategies for weed control using pre-emergence herbicides is urgently required. Therefore, we conducted greenhouse dose–response and field experiments over two wheat growing seasons at two sites in Xinyang City (CaiWan and LaoHuShan) to study resistance levels and effective chemical control strategies using the pre-emergence herbicides flufenacet and pyroxasulfone individually and tank-mixed. Greenhouse studies indicated that the CaiWan and LaoHuShan Japanese foxtail populations had a 5.1–35.3-fold resistance to acetyl-CoA carboxylase inhibitors and a 3.7–9.9-fold resistance to acetolactate synthase inhibitors, respectively. Field experiment data analyses revealed that pre-emergence herbicides applied before wheat sowing and immediately after wheat sowing provided >76% weed density and >82% weed biomass control efficiencies 30 and 90 days after sowing, respectively. They showed significantly higher results than herbicides applied after wheat was sown. Compared to the weedy check (control), flufenacet (300 and 450 g/ha), pyroxasulfone (180 and 240 g/ha), and their tank-mix (flufenacet at 300 + pyroxasulfone at 180 g/ha) significantly reduced weed density and biomass (P < 0.05). The tank-mix of flufenacet + pyroxasulfone consistently provided the highest weed control efficiency (85.3–94.5%). The tank-mix applied immediately after sowing resulted in the highest weed control efficiency (88.9–95.6%), the highest wheat yield (5470.3–5527.3 kg/ha), and no observed wheat injuries. However, multiple strategies, such as pre- and post-emergence herbicides, must be adopted to cope with high-density resistant weeds.

Abstract 1573: Inhibition of acetyl-CoA carboxylase induced spindle abnormalities

Abstract Acetyl-CoA carboxylase (ACC), the rate-limiting enzyme in the de novo fatty acid synthesis pathway, is required for successful cell division in yeast, indicating that fatty acid synthesis may be regulated in order to properly safeguard nuclear and cell division. ACC is also phosphorylated during mitosis and this inhibitory phospho-ACC is accumulated at the spindle pole at metaphases. In this study, we set out to understand the role of ACC in the regulation of mitotic spindle assembly in human cells. We found that inhibition of ACC with TOFA induced spindle defects and cell death. The spindle defects induced by TOFA could be rescued by exogenous palmitic acid (PA), the immediate products of fatty acid synthesis. Inhibiting protein palmitoylating or depalmitoylating enzymes could induced spindle defects. These data indicate that well-regulated cellular PA levels and protein palmitoylation are required to assure accurate spindle assembly. In addition, the spindle microtubules comprised of α-tubulins mutated at the reported palmitoylation site exhibited disrupted dynamic instability. These results reveal that ACC may modulate tubulin palmitoylation during mitosis to delicately control MT dynamic instability and spindle assembly, thereby safeguarding nuclear and cell division. Citation Format: Chieh-Ting Fang, Hsiao-Hui Kuo, Sih-Long Liu, Jhong-Syuan Yao, Ling-Huei Yih. Inhibition of acetyl-CoA carboxylase induced spindle abnormalities [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 1573.

Enlist™ corn tolerance to preemergence and postemergence applications of synthetic auxin and ACCase-inhibiting herbicides

AbstractAllowing the use of two additional modes of action (MOAs), Enlist™ corn is a novelty in the continuum of herbicide-resistant crop development efforts that have occurred since the 1990s. Knowledge of Enlist corn tolerance to labeled herbicides and other herbicides within the same MOA for various use and/or exposure scenarios is not well established. Four site-year field experiments for preemergence (PRE) and postemergence (POST) applications were conducted at sites in Fayetteville (2021 and 2022) and Tillar (2020 and 2021), Arkansas, to evaluate Enlist corn response following PRE or POST applications of synthetic auxin herbicides or those that inhibit acetyl-CoA carboxylase (ACCase). A non-Enlist and an Enlist corn hybrid were used for each herbicide treatment to establish differential tolerance. Injury response to PRE application varied among site-years; clethodim was the only herbicide that occasionally caused significant (7% to 17%) injury to Enlist corn. None of the PRE treatments affected plant height, stand, or yield of Enlist corn; these responses were generally similar or better for Enlist corn compared to non-Enlist corn. Enlist corn showed significant injury to POST applications of florpyrauxifen-benzyl (&gt;10%), fluazifop-P-butyl and quizalofop-P-ethyl (&gt;5%), and clethodim and sethoxydim (&gt;75%) 1 wk after application (WAA). These initial injury responses to clethodim and sethoxydim were generally reflected in Enlist corn yield; however, the minimal injury from fluazifop-P-butyl and quizalofop-P-ethyl did not affect yield. Injury to non-Enlist corn with POST-applied ACCase-inhibiting herbicides 2 WAA was &gt;80%, resulting in a proportionate yield reduction. Even though florpyrauxifen-benzyl caused more initial injury to non-Enlist corn, yield reduction in non-Enlist corn was occasionally less than of Enlist corn, with both hybrids experiencing &gt;75% yield reduction. In summary, Enlist corn may occasionally show transient injury even to labeled herbicides when applied POST, and even though the injury from florpyrauxifen-benzyl is initially mild, it nonetheless results in substantial yield loss.

Glyphosate-resistant downy brome (Bromus tectorum) control using alternative herbicides applied postemergence

AbstractDowny brome is a troublesome facultative winter-annual grass weed that invades agricultural and nonagricultural lands in western North America and can cause substantial crop yield losses particularly in no-till winter wheat. Glyphosate-resistant (GR) downy brome was identified in southern Alberta in 2021, representing the first confirmation of a GR grass weed in Canada. This study was designed to evaluate alternative herbicides and herbicide mixtures applied postemergence (POST) for control of GR and glyphosate-susceptible (GS) downy brome populations at the seedling stage under a controlled environment. The GR downy brome did not exhibit cross-resistance to other herbicides applied POST. Quizalofop alone or in combination with imazamox, imazamox + bentazon, or imazamox/imazethapyr, and glufosinate mixed with either clethodim or tiafenacil resulted in ≥80% visible control, plant mortality, and reduction in biomass of both GR and GS downy brome populations 21 d after treatment. Diligent stewardship of these remaining herbicide options is warranted since downy brome populations with resistance to herbicides that inhibit acetyl-CoA carboxylase or acetolactate synthase have been reported in neighboring states.

Metabolic cross-resistance to florpyrauxifen-benzyl in barnyardgrass (Echinochloa crus-galli) evolved before the commercialization of Rinskor™

AbstractHerbicide options for selective control of monocot weeds in rice (Oryza sativa L.) have historically been limited to a few modes of action such as inhibitors of acetolactate synthase (e.g., penoxsulam, imazamox), photosystem II (e.g., propanil), and acetyl-CoA carboxylase (e.g., cyhalofop). Florpyrauxifen-benzyl (Rinskor™) is a synthetic auxin molecule introduced to the U.S. rice herbicide market in 2018, providing broad-spectrum weed control (monocots and dicots), including hard-to-control species such as barnyardgrass [Echinochloa crus-galli (L.) P. Beauv.], along with postemergence rice selectivity at very low use rates. Within the year of commercialization, field agronomists and academics identified E. crus-galli escapes in some areas where florpyrauxifen-benzyl had been sprayed. Further evaluation under controlled environments confirmed that those plants were able to survive florpyrauxifen-benzyl application at the label rate. Here, we identify the mechanism of resistance to florpyrauxifen-benzyl and penoxsulam in two E. crus-galli populations from Arkansas (AR-27) and Missouri (MO-18). Using high-resolution mass spectrometry, we compared the two resistant biotypes with known susceptible plants regarding their ability to metabolize florpyrauxifen-benzyl, florpyrauxifen-acid, and penoxsulam in planta. We discovered that the resistant plants share a common resistance mechanism to florpyrauxifen-benzyl and penoxsulam, involving hydrolysis of a methoxy group (likely mediated by a cytochrome P450 monooxygenase) followed by glucose conjugation. Given that penoxsulam has been widely used in rice fields for the past decade, these data suggest that some populations of E. crus-galli may have evolved resistance before the commercialization of florpyrauxifen-benzyl.